1023/1.11. 0.0 - 0.1 Coap. Netabolic Panel (14) Glucose 128 High ng/dL 65 - 99 Sample is lipeaio. This may causa spurious increases in TBili, DBili, AST, ALT, and UIBC (if ordared). Clinical correlation indicated. Specimen received beaolyxed. Clinical corralation indicated. 01 01 01 01 01

n/1.73 >59 mL/min/1.73 >59 10 - 24 mmol/L 134 - 144 01 4.2 mmol/L 3.5 - 5.2 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and UIBC (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. al 01 Chloride 1

ucose, 128 Nigh mg/d3/ 65 - 99 01 Sample is lipemic. This may cause AST, ALT, and 13IBC (if ordered). spurious Clinical increases in TBili, DBili, correlation indicated. Physician Details OrderMg: W MERRELL Mewing: D: MERRELL 14M: 1023153509 Fatting: No Specimen received hemolysed. Cli

- 27 0.76 - 1.27 01 >59 >59 10 - 24 mMO1/L 134 - 144 01 anol/L 3.5 - 5.2 01 Sample is lipemic. This may cause spurious increases in IBM, DBili, AST, ALT, and UIBC (if ordered). Clinical correlation indicated Specimen received hemolyzed. Clinical correlation indicated. Chloride 102 mmol/

) Glucose 128 High mg/dL 65 - 99 01 Sample is lipamic. This may cause spurious AST, ALT, and GIBC (if ordered). Clinical increases in TBili, DBili, correlation indicated. Rte: 68 Fasting: No Specimen received hemolyzed. Clinical correlation indicated. Date Issued: 09/1&181053 ET PRELIMINAR

uL 0.0 - 0.1 01 Comp. Metabolic Panel (14) Glucose 128 High mg/dL 65 - 99 01 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and =X (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. Datehmed:09/20/160032